MET and head and neck squamous cell carcinoma: To explore these findings within clinical data, we analyzed the proteomic dataset of patients with HNSCC (n = 212) within the TCGA database that contains results for phosphorylated c-MET protein at tyrosine 1235 (Y1235) measured by reverse phase protein array, which is indicative of an activated kinase status.